For the second year running, ROVI has obtained the best ranking in the pharmaceutical industry category in the world rating of environmental, social and corporate governance (ESG) risks drawn up by Sustainalytics, a leading independent ESG research, rating and analytics firm that supports investors around the world with the development and implementation of responsible investment strategies. ROVI has revalidated its first place among 431 companies rated in the pharmaceutical industry group and remains in 22nd place among a total of 895 companies rated in the entire sector, which includes “biotechnology companies, pharmaceutical laboratories and laboratory equipment companies.”
In the rating process, Sustainalytics has analysed the company’s performance in sustainability aspects considered material in the pharmaceutical sector, highlighting ROVI’s sound management of ESG risks related to product quality and safety, corporate governance, business ethics, human capital, the fight against climate change and anti-corruption and anti-bribery practices. ROVI has obtained a higher-than-average score in areas such as the board’s involvement in the company’s environmental and social aspects, implementation of the environmental policy and a sound quality and safety programme for products and services, as well as the integration of ethical practices into all tiers of the organisation.
You may consult ROVI’s rating on this link: https://www.rovi.es/sites/default/files/laboratorios_farmaceuticos_rovi_sa_riskratingssummaryreport_08_03_2023.pdf
Commitment to sustainability
In 2022, ROVI approved its ESG Master Plan 2023-2025, a document that sets out 19 strategic ESG goals. With a three-year horizon, the Group has established a roadmap for attaining the Sustainable Development Goals (SDGs) of the United Nations Agenda 2030, with which ROVI, as a member of the Global Compact, is aligned.
The Group focuses its action on five priority areas:
– Becoming a leader in governance committed to sustainability.
– Commitment to sustainable management to combat the global environmental challenges: fight against climate change, promotion of the circular economy and efficient water management.
– Positioning itself as a key player in caring for persons and integrating specialised and diverse talent.
– Promoting responsible management of the supply chain, ensuring ethical and environmental standards in each one of its links.
– Promoting R&D&I activities by establishing partnerships with key players.
